Santo Borganelli, MD
Clinical Cardiac Electrophysiology · Hattiesburg, MSNPI 1235139866
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Cook Incorporated at 38.5% of the total. Reporting peaked in 2019 at $6,197 and has fallen 81.1% since, to $1,171 in 2025.
Across 201 payments — averaging $77.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$6K
- Medtronic$4K
- Boston Scientific$1K
- Cook Medical LLC$1K
- Atricure, Inc.$1K
- Biosense Webster, Inc.$677
- plus $1K from 19 others
What the payments were for
- Speaking & faculty fees$5,97038%
- Travel & lodging$3,40322%
- Food & beverage$6,13540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 2 | $5,970 |
| Medtronic(2 entities) | 68 | $3,555 |
| Boston Scientific | 35 | $1,465 |
| Cook Medical LLC | 12 | $1,456 |
| Atricure, Inc. | 13 | $1,351 |
| Biosense Webster, Inc. | 25 | $677 |
| Abiomed | 9 | $167 |
| Novartis | 7 | $124 |
| E.r. Squibb & Sons, L.L.C. | 3 | $98 |
| Biotronik Inc. | 3 | $88 |
| Infobionic, Inc | 1 | $81 |
| Abbott | 3 | $65 |
| Pfizer | 4 | $64 |
| Livanova USA, Inc. | 1 | $63 |
| Philips North America LLC | 2 | $45 |
| Cardiva Medical, Inc. | 2 | $44 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $42 |
| AstraZeneca | 3 | $41 |
| Impulse Dynamics (USA) Inc. | 1 | $25 |
| Stryker | 1 | $16 |
| GE HealthCare | 1 | $16 |
| Terumo Medical Corporation | 1 | $15 |
| Merck | 1 | $14 |
| Baylis Medical Company Inc | 1 | $12 |
| Boehringer Ingelheim | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Cook Medical Lead Management$4,500
- Evolution$1,583
- Cook Medical Lead Management - Lead Extraction$982
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$949
- Carto 3$237
- PulseSelect$227
- Compia MRI$142
- Rhythmia Mapping System$116
- AFFERA MAPPING SYSTEM$114
- WATCHMAN Access System$113
- GENERAL - THERAPIES$113
- DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$110
- Watchman$108
How this compares
Too few clinical cardiac electrophysiology providers in Mississippito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 673 | $535,899 |
| XareltoRivaroxaban | 178 | $147,787 |
| Dofetilide | 370 | $43,286 |
| EntrestoSacubitril/Valsartan | 36 | $33,798 |
| CorlanorIvabradine Hcl | 27 | $15,107 |
| JardianceEmpagliflozin | 14 | $9,715 |
| Flecainide Acetate | 270 | $7,864 |
| Metoprolol Succinate | 665 | $7,544 |
| Amiodarone Hcl | 430 | $5,647 |
| Potassium Chloride | 236 | $3,250 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 13 | $3,091 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 105 | $1,121 |
| Midodrine Hcl | 25 | $1,080 |
| Carvedilol | 143 | $1,065 |
| Metoprolol Tartrate | 125 | $821 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $64 | $535,899673 claims |
| NovartisEntresto | $124 | $33,79836 claims |
| Boehringer IngelheimJardiance | $12 | $9,71514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical cardiac electrophysiology providers in Mississippion file to place this against a meaningful peer group, so we don't.
Other clinical cardiac electrophysiology in Hattiesburg
- Diego Alcivar FrancoHattiesburg$14K
- Karthik Venkatesh PrasadTupelo$86K
- James StoneTupelo$61K
- Elsheikh AbdelrahimTupelo$35K
- James Hamilton IvJackson$34K
- Jimmy LottJackson$16K
- Attila RokaMeridian$16K
- Sandra McCearleyJackson$10K
- Douglas WolfeJackson$9K
- Joseph OwenJackson$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.